Get an alert when CELLTECH R&D LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-04-14 (in 11mo)

Last made up 2026-03-31

Watchouts

None on the register

Cash

£35K

-89.3% vs 2023

Net assets

£52M

+33.1% vs 2023

Employees

618

-1.9% vs 2023

Profit before tax

£2M

+33.3% vs 2023

Name history

Renamed 4 times since incorporation

  1. CELLTECH R&D LIMITED 2001-04-02 → present
  2. CELLTECH CHIROSCIENCE LIMITED 2000-05-16 → 2001-04-02
  3. CELLTECH THERAPEUTICS LIMITED 1994-10-03 → 2000-05-16
  4. CELLTECH LIMITED 1980-12-31 → 1994-10-03
  5. ALNERY NO.31 LIMITED 1980-01-11 → 1980-12-31

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £88,019,000£101,137,000
Operating profit £60,000£56,000
Profit before tax £1,402,000£1,869,000
Net profit £1,773,000£1,762,000
Cash £328,000£35,000
Total assets less current liabilities
Net assets £39,145,000£52,084,000
Equity £39,145,000£52,084,000
Average employees 630618
Wages £56,954,000£63,918,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 0.1%0.1%
Net margin 2.0%1.7%
Current ratio 15.78x9.31x
Interest cover 20.00x7.00x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Forvis Mazars LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The financial statements have been prepared on a going concern basis, which assumes that the Company will continue trading for a period of at least 12 months from the date of these financial statements. The directors have reviewed the sales forecasts, the cash flow projections, and the growth drivers of the business and came to conclusion that the Company has sufficient liquidity position to pay to its creditors, even though major part of liabilities are intercompany balances and company does not use external financing. The Company's directors have assessed that there are no material uncertainties that may cast significant doubt on the ability of the Company to continue as a going concern. Thus, the directors believe that it is appropriate to adopt the going concern basis of accounting in preparing the annual financial statements”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 47 resigned

Name Role Appointed Born Nationality
KHATRI, Yogesh Director 2013-06-24 Oct 1965 British
REYNDERS, Nico Victor Director 2024-12-01 Aug 1972 Belgian
Show 47 resigned officers
Name Role Appointed Resigned
HARDY, Mark Glyn Secretary 2004-10-29 2023-10-01
SLATER, John Andrew Duncan Secretary 2004-10-29
ALLEN, Peter Vance Director 1992-02-27 2004-12-17
ANDO, Goran Albert Torstensson, Doctor Director 2003-04-16 2004-10-29
ARTUS, Ronald Edward Director 1991-04-24
BAINS, Harbinder Singh Director 2005-05-10 2006-02-28
BENTLEY, Michael John Director 1992-06-04 1993-10-01
BERRIMAN, John Edward Director 1995-01-16 1996-04-26
BERRIMAN, John Edward Director 1994-10-03
BIRCH, John Robert Director 1992-06-04
BLOXHAM, David Phillip Director 1997-12-08
BRADING, Claire Director 2021-01-01 2024-12-01
COOMBES, Dan Director 2018-10-08 2021-01-01
DE CANNART D'HAMALE, Michele Director 2005-06-22 2011-04-29
DIFFERDING, Edmond Director 2009-05-25 2010-04-01
DIFFERDING, Edmond Director 2007-12-13 2009-05-25
DONCK, Jean-Christophe Director 2009-05-25 2011-05-31
DONCK, Jean-Christophe Director 2007-12-13 2009-05-25
FELLNER, Peter John, Dr Director 2003-04-16
HARDY, Mark Glyn Director 2004-12-17 2023-10-01
HUCKLE, John George Director 1991-10-30
JACKSON, John Bernard Haysom Director 1993-10-01
JACKSON, Robert Charles, Doctor Director 1999-09-29 2000-05-25
JOHNSCHER, Gerd Director 2007-12-13 2009-05-25
JONES, Stephen Charles Director 2006-02-28 2013-06-30
KLITGAARD, Henrik Valdemar Director 2009-05-25 2011-05-31
KLITGAARD, Henrik Valdemar Director 2007-12-13 2009-05-25
LEE, Melanie Georgina, Doctor Director 1998-09-24 2009-08-31
LORD PHILLIPS OF ELLESMERE, Lord Director 1993-10-01
MYNERS, Paul Director 1991-04-24
NEY, Ursuala Mary, Dr Director 2000-10-31 2001-12-31
NICHOLLS, Peter Geoffrey Director 2005-01-31 2009-10-02
NORRIS, Allen Edwin Director 2009-05-25 2011-05-31
NORRIS, Allen Edwin Director 2007-12-13 2009-05-25
OLUWA, Olufunlayo Modupe Director 2024-01-01 2024-12-01
ROELANDT, Erik Director 2005-06-22 2010-07-24
ROSS, Iain Gladstone Director 1991-06-27 1995-10-31
SEYMOUR, Donald Edwin Director 1991-04-24
SIDDALL, Sidney Stewart Director 1991-04-24 1993-10-01
SIDI-SAID, Hocine Director 2007-12-13 2009-05-25
SODEN, Christine Helen Director 1999-09-29 1999-11-10
THIAN, Robert Peter Director 1991-04-24 1993-10-01
TURLEY, Stephen Director 2017-04-13 2018-10-08
VAN DER TOORN, Adriaan Cornelis Director 2010-07-24 2014-12-17
VERMEESCH, Luc Director 2009-05-25 2014-04-04
VERMEESCH, Luc Director 2007-12-13 2009-05-25
WOOD, Martin Francis, Sir Director 1992-06-04

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Celltech Group Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 213 total filings

Date Type Category Description
2026-04-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-08-13 AA accounts Accounts with accounts type full
2025-04-11 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-12-05 AP01 officers Appoint person director company with name date PDF
2024-12-04 TM01 officers Termination director company with name termination date PDF
2024-12-04 TM01 officers Termination director company with name termination date PDF
2024-10-12 AA accounts Accounts with accounts type full
2024-04-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-01-04 AP01 officers Appoint person director company with name date PDF
2023-10-06 TM01 officers Termination director company with name termination date PDF
2023-10-06 TM02 officers Termination secretary company with name termination date PDF
2023-08-09 AA accounts Accounts with accounts type full
2023-04-12 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-02-27 AA accounts Accounts with accounts type full
2022-04-08 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-01-21 AUD auditors Auditors resignation company
2021-10-11 AA accounts Accounts with accounts type full
2021-04-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-01-21 CH01 officers Change person director company with change date PDF
2021-01-14 AP01 officers Appoint person director company with name date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page